References
Abe, I., Islam, F., and Lam, A.K.Y. (2020). Glucose intolerance on phaeochromocytoma and paraganglioma—the current understanding and clinical perspectives. Front Endocrinol 11, 593780.
American Diabetes Association Professional Practice Committee. (2022). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2022. Diabetes Care 45, S17–S38.
Beninato, T., Kluijfhout, W.P., Drake, F.T., Lim, J., Kwon, J.S., Xiong, M., Shen, W.T., Gosnell, J.E., Liu, C., Suh, I., et al. (2017). Resection of pheochromocytoma improves diabetes mellitus in the majority of patients. Ann Surg Oncol 24, 1208–1213.
Elenkova, A., Matrozova, J., Vasilev, V., Robeva, R., and Zacharieva, S. (2020). Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma/paraganglioma: retrospective single-center study. Ann Endocrinol 81, 3–10.
Guerrero, M.A., Schreinemakers, J.M.J., Vriens, M.R., Suh, I., Hwang, J., Shen, W.T., Gosnell, J., Clark, O.H., and Duh, Q.Y. (2009). Clinical spectrum of pheochromocytoma. J Am Coll Surg 209, 727–732.
Khatiwada, S., Agarwal, S., Kandasamy, D., Jyotsna, V.P., Kumar, R., Kumar Bansal, V., Pandey, R.M., Gupta, N., and Tandon, N. (2020). Diabetes mellitus in pheochromocytoma and paraganglioma: prevalence, dynamics of insulin secretion/sensitivity and predictors of remission. Diabetes Metab Syndr 14, 2169–2175.
Komada, H., Hirota, Y., So, A., Nakamura, T., Okuno, Y., Fukuoka, H., Iguchi, G., Takahashi, Y., Sakaguchi, K., and Ogawa, W. (2017). Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma. J Clin Endocrinol Metab 102, 3400–3405.
Krumeich, L.N., Cucchiara, A.J., Nathanson, K.L., Kelz, R.R., Fishbein, L., Fraker, D.L., Roses, R.E., Cohen, D.L., and Wachtel, H. (2021). Correlation between plasma catecholamines, weight, and diabetes in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 106, e4028–4038.
Mesmar, B., Poola-Kella, S., and Malek, R. (2017). The physiology behind diabetes mellitus in patients with pheochromocytoma: a review of the literature. Endocrine Pract 23, 999–1005.
Neumann, H.P.H., Young, W.F. Jr., and Eng, C. (2019). Pheochromocytoma and paraganglioma. N Engl J Med 381, 552–565.
Acknowledgements
This work was supported by the National Key Research and Development Program of China (2016YFC1300100), the CAMS Innovation Fund for Medical Sciences (2022-I2M-C&T-A-010, 2022-I2M-C&T-B-041), and National High Level Hospital Clinical Research Funding (2022-PUMCH-D-005, 2022-PUMCH-B-110).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Compliance and ethics The author(s) declare that they have no conflict of interest. Ethics approval for this study was granted by the ethics committee of Peking Union Medical College Hospital and the study also followed the Declaration of Helsinki.
Supporting information
Rights and permissions
About this article
Cite this article
Zhao, L., Meng, X., Zhang, Q. et al. Factors associated with dysglycemia and its post-surgical resolution in patients with pheochromocytomas. Sci. China Life Sci. 66, 411–414 (2023). https://doi.org/10.1007/s11427-022-2282-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-022-2282-1